There are several possible explanations of this result: the location of the CD19 epitope recognized by the FMC63 mAb is not membrane-proximal, there are no steric inhibitory effects between FMC63 mAb and its epitope, or the density of the CD19 molecule on tumor cells is high [50]. Here, CD19 is linked to neoplasm.